Patents by Inventor Justin Changjoon Lee

Justin Changjoon Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120232127
    Abstract: A novel use of anion channels, preferably Ca2+-activated anion channels (CAACs), in regulating release of neurotransmitters from neurons and/or astrocytes is provided. More specifically, CAAC activity regulators, agents for regulating neurotransmitter release comprising such CAAC activity regulators, and methods of screening agents for regulating neurotransmitter release using CAAC as a target.
    Type: Application
    Filed: March 13, 2012
    Publication date: September 13, 2012
    Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Justin Changjoon LEE, Dong-Ho Woo, Hyung-Ju Park, Hye-Kyung Park
  • Publication number: 20110201668
    Abstract: A novel use of anion channels, preferably Ca2+-activated anion channels (CAACs), in regulating release of neurotransmitters from neurons and/or astrocytes is provided. More specifically, CAAC activity regulators, agents for regulating neurotransmitter release comprising such CAAC activity regulators, and methods of screening agents for regulating neurotransmitter release using CAAC as a target.
    Type: Application
    Filed: January 30, 2008
    Publication date: August 18, 2011
    Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Justin Changjoon Lee, Dong-Ho Woo, Hyung-Ju Park, Hye-Kyung Park
  • Publication number: 20110059994
    Abstract: A composition for preventing and/or treating brain tumor, containing caffeine and/or its analog, and/or their pharmaceutically acceptable salt, as an active ingredient, is provided. The composition for preventing or treating brain tumor has an activity to inhibit invasion, migration, and proliferation of brain tumor cells, and thereby very effective for the prevention and treatment of brain tumor.
    Type: Application
    Filed: January 31, 2008
    Publication date: March 10, 2011
    Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Justin Changjoon Lee, Eun-Joo Roh, Jin-Kyu Choi, Kyung-Suk Han, Jung-Eun Park, Sang-Soo Kang
  • Publication number: 20110039869
    Abstract: An agent for inhibiting the activity of inositol-1,4,5-triphospate receptor subtype 3 (IP3R3), containing caffeine and/or its analogs, and/or their pharmaceutically acceptable salts, as an active ingredient, is provided. A composition for preventing and/or treating a disease associated with Ca2+ release through IP3R3, containing the IP3R3 inhibiting agent, is also provided.
    Type: Application
    Filed: January 31, 2008
    Publication date: February 17, 2011
    Applicant: Korea Institute of Science and Technology
    Inventors: Justin Changjoon Lee, Sang-Soo Kang, Kyung-Suk Han, Eun-Joo Roh, Jae-Yong Park